Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Crescent Biopharma (Nasdaq: CBIO) management will present in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York on Thursday, February 12, 2026 at 11:30 a.m. ET.

Rhea-AI Summary

Crescent Biopharma (Nasdaq: CBIO) management will present in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York on Thursday, February 12, 2026 at 11:30 a.m. ET. A live webcast will be available in the Investors section and a replay will be accessible for 90 days.

Argus Feb 5 session

-3.09% close to close Open Argus

Details

News Market Reaction – CBIO

On Feb 5, the day this news came out, CBIO closed 3.09% below the previous close.

Data tracked by StockTitan Argus for the Feb 5 session.

Market Context

This announcement highlights Crescent Biopharma’s planned participation in the Guggenheim Emerging O...

Analysis

This announcement highlights Crescent Biopharma’s planned participation in the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026, offering additional visibility to its oncology pipeline. The webcast and 90-day replay provide broad access for investors to hear management’s messaging. In the months prior, Crescent reported major partnership, financing, and IND clearance milestones, so investors may watch this event for any incremental commentary on timing and execution of these previously disclosed plans.

Key Figures

Summit date: February 12, 2026 Presentation time: 11:30 a.m. ET Webcast replay period: 90 days

Summit date

February 12, 2026

Scheduled Guggenheim Emerging Outlook: Biotech Summit 2026 appearance

Presentation time

11:30 a.m. ET

Time of fireside chat at Guggenheim Biotech Summit

Webcast replay period

90 days

Replay availability in Investors section of company website

Historical Context

5 past events · Latest: Jan 30

5 events

1. Jan 30

   Inducement option grants

   24h Move

   +2.4%

   Equity option awards to new employees under inducement plan with standard terms.

2. Jan 05

   IND clearances

   24h Move

   +0.3%

   U.S. and China regulatory clearances for CR-001 and CR-003 solid tumor programs.

3. Dec 18

   Inducement option grants

   24h Move

   -3.0%

   Employee option grants with 10-year term and vesting, seen with negative price move.

4. Dec 04

   Financing & partnership

   24h Move

   -4.2%

   Kelun-Biotech partnership and $185M private placement to fund global pipeline.

5. Dec 04

   Strategic partnership

   24h Move

   -4.2%

   Strategic oncology collaboration with Kelun-Biotech on CR-001 and SKB105 programs.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York on Thursday, February 12, 2026 at 11:30 a.m. ET.

A live webcast of the presentation will be available in the Investors section of the Company's website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days following the event.

About Crescent Biopharma

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.

Contact:

Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Crescent Biopharma (CBIO) present at the Guggenheim Biotech Summit 2026?

Crescent Biopharma will present on February 12, 2026 at 11:30 a.m. ET. According to the company, management will participate in a fireside chat during the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, offering investor-focused remarks and Q&A.

How can investors watch Crescent Biopharma's (CBIO) webcast on February 12, 2026?

Investors can watch a live webcast via the company's Investors page at the provided events and presentations link. According to the company, the webcast will stream live and a replay will be posted for on-demand viewing for 90 days after the event.

Will Crescent Biopharma (CBIO) provide a replay of the Guggenheim presentation and for how long?

Yes, a replay will be available for 90 days following the event. According to the company, the replay will be accessible in the Investors section of the website for on-demand review after the live fireside chat concludes.

What topics will Crescent Biopharma (CBIO) cover in the Guggenheim fireside chat on Feb 12, 2026?

The company announced management will speak on its clinical-stage programs and strategy during the fireside chat. According to the company, remarks will focus on development progress and corporate outlook relevant to investors and analysts attending the summit.

Where is the Guggenheim Emerging Outlook: Biotech Summit 2026 presentation location for Crescent Biopharma (CBIO)?

The in-person presentation takes place in New York at the Guggenheim Emerging Outlook: Biotech Summit 2026. According to the company, management will appear on stage for a fireside chat and the session will also be webcast for remote investors.